We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
The MHRA's initial plans on an Early Access service, which will be developed further throughout 2025.
The UK government has introduced the Northern Ireland MHRA Authorised Route (NIMAR). This new route for supply became operational 1 January 2022.
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
A user guide for understanding and applying the national taxonomy for incident learning in clinical imaging, magnetic resonance imaging and nuclear medicine.
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
Information for retailers from Great Britain supplying medical devices to Northern Ireland.
How the MHRA assesses marketing authorisation applications (MAA) for medicines referred under Article 29.
Guidance for industry on preparing responses to good laboratory practice (GLP) and good clinical practice (GCP) inspection reports.
Webinars for pharmaceutical companies, clinical trial sponsors, e-cigarette producers and brokers of medicinal products
An overview of the five technologies selected for the AI Airlock pilot.
Helps manufacturers and healthcare professionals understand the definition of assistive technology and the difference between medical devices and aids to daily living.
Labelling requirements for e-liquids.
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
A pathway summarising the processes pharmaceutical companies should follow when preparing to launch new products in the UK.
Instructions for integrating with the new production MORE platform API.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).